Area of research
Genetics · Hematology
Research interest
Research interests include Chronic Lymphocytic Leukemia Research, Lymphoma Diagnosis and Treatment, Acute Myeloid Leukemia Research, and Complement system in diseases.
ASH 2026 Guidelines for Frontline Management of Acute Lymphoblastic Leukemia in Adolescents and Young Adults
Preclinical evaluation of CD70-specific CAR T cells targeting acute myeloid leukemia
Acute myeloid leukemia cells and MSC-derived exosomes inhibiting transformation in myelodysplastic syndrome
Venetoclax retreatment of patients with chronic lymphocytic leukemia after a previous venetoclax-based regimen
COVID-19 in patients with CLL: improved survival outcomes and update on management strategies
Novel agents and regimens for hematological malignancies: recent updates from 2020 ASH annual meeting
CD70‐targeting CAR‐T cells have potential activity against CD19‐negative B‐cell Lymphoma
Outcomes of COVID-19 in patients with CLL: a multicenter international experience
Assessment of the Efficacy of Therapies Following Venetoclax Discontinuation in CLL Reveals BTK Inhibition as an Effective Strategy
Alternative Polyadenylation: a new frontier in post transcriptional regulation
Efficacy of bendamustine and rituximab in unfit patients with previously untreated chronic lymphocytic leukemia. Indirect comparison with ibrutinib in a real‐world setting. A GIMEMA‐ERIC and US study
Real-world outcomes and management strategies for venetoclax-treated chronic lymphocytic leukemia patients in the United States
Outcomes of CLL patients treated with sequential kinase inhibitor therapy: a real world experience
Favorable Outcomes in CLL Pts with Alternate Kinase Inhibitors Following Ibrutinib or Idelalisib Discontinuation: Results from a Large Multi-Center Study